| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to hematology, cardiology, endocrinology, and can be applied for normalisation of microvesicle level in blood in case of glucose tolerance disturbance. For this purpose introduced is pioglitazone 30 mg 1 time in the morning and dosed physical loadings are prescribed. Duration of treatment is not less than 6 weeks. ^ EFFECT: method results in normalisation of microvesicle level in blood of patients of said category, reducingmanifestations, including, endothelial dysfunction, as well as considerably reducing hemocoagulation potential of blood, reducing risk of thrombotic complications. ^ 1 ex |
